AMANDA ZAJCHOWSKI: Open Payments
NPI 1982381646 · LIVE OAK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 39 payments from 12 companies in 2025. Trend: 2023 $136 · 2024 $888 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $255 |
| Lilly USA, LLC | 9 | $160 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $100 |
| ABBVIE INC. | 4 | $80 |
| GlaxoSmithKline, LLC. | 5 | $76 |
| Novo Nordisk Inc | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| PFIZER INC. | 2 | $39 |
| Exact Sciences Corporation | 2 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
Products named: AIRSUPRA, MOUNJARO, JARDIANCE, TRELEGY ELLIPTA, Ozempic, CAPLYTA, QULIPTA, VRAYLAR.
Industry payments across FL — which companies pay providers there.
